An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
About this study
The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.
- Condition
- Rectal Cancer, Self Efficacy
- Tested
- PATHWAYS, Enhanced usual care
- Sponsor
- Massachusetts General Hospital
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 18 years
- Study condition: Rectal Cancer, Self Efficacy
- Ageā„18 years
- Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
- Able to complete study procedures English or with the assistance of an interpreter
Exclusion 2
- Comorbid health condition that would interfere with study participation, as identified by cancer care team
- Has undergone treatment for a prior colorectal cancer
Where
2 sites, 2 recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Contact
-
Kelsey Lau-Min, MD, MSCE
617-724-4000 klau-min@mgh.harvard.edu
Potential match only. Final eligibility is determined by the study team.